Inventor

OSBORNE JAMES

US10 patents

⚠️ This page may combine multiple inventors who share the name “OSBORNE JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LAVIPHARM LAB INC

2 patents

US6552024B1Apr 22, 2003

Compositions and methods for mucosal delivery

LAVIPHARM LAB INC271 citations96

US7247315B2Jul 24, 2007

Compositions and medical device for transdermal delivery of a drug and methods of making and using same

LAVIPHARM LAB INC5 citations52

SRAM CORP

2 patents

US7163223B2Jan 16, 2007

Lockout mechanism for a suspension system

SRAM CORP57 citations94

US7090308B2Aug 15, 2006

Axle assembly for mounting a wheel to a vehicle

SRAM CORP59 citations93

QUSPIN INC

2 patents

US10775450B1Sep 15, 2020

Zero field parametric resonance magnetometer with triaxial sensitivity

QUSPIN INC13 citations81

US12543969B2Feb 10, 2026

Multilayer PCB-based coil array for sensor localization in magnetoencephalography

QUSPIN INC0 citations43

CANCER RESEARCH TECH LTD

2 patents

US11787792B2Oct 17, 2023

5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof

CANCER RESEARCH TECH LTD1 citations70

US10259806B2Apr 16, 2019

5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof

CANCER RESEARCH TECH LTD2 citations70

CANCER RES TECH LTD

1 patent

US9663503B2May 30, 2017

5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof

CANCER RES TECH LTD5 citations81

ALMIRALL SA

1 patent

US10214509B2Feb 26, 2019

Amino-substituted heterocyclic derivatives as sodium channel inhibitors

ALMIRALL SA0 citations37